-+ 0.00%
-+ 0.00%
-+ 0.00%

OBSIDIAN THERAPEUTICS, INC : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $32

Reuters·09/22/2026 10:08:24

Please log in to view news